Variable

Number of cases

Age (years)

 

 Means ± standard deviation

57 ± 10

 Range

32 – 75

Gender (M/F) Etiology  HBV  HCV Alcohol  Idiopathic Type of tumor  Massive Diffuse  Diffuse  Multi-nodular  Single PVTT  Yes  No Grade of PVTT Vp0  Vp1  Vp2  Vp3  Vp4 Child-Pugh Class A / B /C Albumin (g/dL) ≥ 3.5 / 〈 3.5 Bilirubin (mg/dL) ≤ 1.2 / 〉 1.2 PT (INR) ≤ 1/ 〉 1 ALT (U/I) ≤ 40 / 〉 40 AFP (ng/mL) ≥ 200 〈 200 Ascites  No/Well controlled/Poor controlled Previous treatment Transcatheter arterial chemoembolization  Percutaneous ethanol injection  Operation Follow-up period (days)  Median (range) NO. decreased patients

47 (87.0%)/ 7 (13.0%)

38 (70.3%) 6 (11.1%) 7 (13.0%) 3 (5.6%)

32 (59.3%) 13 (24.1%) 9 (16.7%) 0 (0%)

40 (74.1%) 14 (25.9%)

14 (25.9%) 0 (0%) 6 (11.1%) 16 (29.6%) 18 (33.3%) 33 (61.1%)/ 17 (31.5%)/ 4 (7.4%)

21 (38.9%)/ 33 (61.1%)

23 (42.6%)/ 31 (57.4%)

8 (14.8%)/ 46 (85.2%)

28 (51.9%)/ 26 (48.1%)

33 (61.1%) 21 (38.9%)

42 (77.8%)/ 9 (16.7%)/ 2 (3.7%)

24 (88.9%) 2 (7.4%) 1 (3.7%)

119 (52 – 1537) 51/ 54 (94.4%)
HBV: Hepatitis B Virus; HCV: Hepatitis C Virus; PVTT: Portal Vein Tumor Thrombosis; Vp0: Absence of invasion of (or tumor thrombus in) the portal vein; Vp1: Invasion (or tumor thrombus in) distal to the second order branches of the portalvein, but not of the second order branches; Vp2: Invasion of (or tumor thrombus in) second order branches of the portal vein; Vp3: Invasion of (or tumor thrombus in) first order branches of the portal vein; Vp4: Invasion of (or tumor thrombus in) the main trunk of the portal veinand/or contra-lateral portal vein branch to the primarily involved lobe; PT: Prothrombin Time; INR: International Normalized Ratio; ALT: Alanine Transaminase: AFP: Alpha-fetoprotein; HAIC: Hepatic Arterial Infusion Chemotherapy; 5-FU: Fluorouracil
Table 1: Baseline Characteristics of Patients.